In vivo bone formation by human bone marrow stromal cells: Effect of carrier particle size and shape

被引:1
|
作者
Mankani, MH
Kuznetsov, SA
Fowler, B
Kingman, A
Robey, PG
机构
[1] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA
[2] Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA
[3] Natl Inst Dent & Craniofacial Res, Off Director, NIH, Bethesda, MD USA
关键词
bone formation; bone marrow stromal cells; transplantation; hydroxyapatite-tricalcium phosphate;
D O I
10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Successful closure of bone defects in patients remains an active area of basic and clinical research. A novel and promising approach is the transplantation of human bone marrow stromal cells (BMSCs), which have been shown to possess a significant osteogenic potential. The extent and quality of bone formation by transplanted human BMSCs strongly depends on the carrier matrix with which cells are transplanted; to date, by hydroxyapatite/tricalcium phosphate (HA/TCP) supports far more osteogenesis than any other matrix tested. In order to further improve the technique of BMSC transplantation, we studied whether commercially available HA/TCP particles, clinically approved as an osteoconductive material and commercially available as particles measuring 0.5-1.0 mm diameter, is an optimum matrix for promoting bone development by BMSCs. HA/TCP and HA particles of varying size were sieved into a variety of size ranges, from <0.044 mm to 1.0-2.0 mm. Transplants were formed by mixing 40 mg aliquots of particles with cultured passaged human BMSCs. They were placed in subcutaneous pockets in immunocompromised Bg-Nu-XID mice and harvested 4 or 10 weeks later. The transplants were examined histologically; the presence of bone within each transplant was evaluated using histomorphometry or blindly scored on a semiquantitative scale. Transplant morphology and the amount of new bone varied in a consistent fashion based on particle size and shape. Transplants incorporating HA/TCP particles of 0.1-0.25 mm size demonstrated the greatest bone formation at both 4 and 10 weeks; larger or smaller particles were associated with less extensive bone formation, while a size of 0.044 mm represented a threshold below which no bone formation could be observed. Flat-sided HA particles measuring 0.1-0.25 mm formed no bone. The differences in bone formation were not attributable to the differences in cell attachment among the groups. Instead, the size and spatial and structural organization of the particles within BMSC transplants appear to determine the extent of bone formation. These findings provide necessary information for the successful clinical application of BMSC transplantation techniques. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:96 / 107
页数:12
相关论文
共 50 条
  • [41] Culture-expanded human bone marrow stromal stem cells organize functional bone marrow niches in vivo.
    Miura, Y
    Gao, ZG
    Miura, M
    Seo, BM
    Sonoyama, W
    Chen, WJ
    Gronthos, S
    Zhang, L
    Shi, ST
    BLOOD, 2005, 106 (11) : 651A - 651A
  • [42] Pedicled bone flap formation using transplanted bone marrow stromal cells
    Mankani, MH
    Krebsbach, PH
    Satomura, K
    Kuznetsov, SA
    Hoyt, R
    Robey, PG
    ARCHIVES OF SURGERY, 2001, 136 (03) : 263 - 270
  • [43] In Vitro Osteogenic Induction of Bone Marrow Stromal Cells with Encapsulated Gene-Modified Bone Marrow Stromal Cells and In Vivo Implantation for Orbital Bone Repair
    Deng, Yuan
    Zhou, Huifang
    Yan, Chenxi
    Wang, Yefei
    Xiao, Caiwen
    Gu, Ping
    Fan, Xianqun
    TISSUE ENGINEERING PART A, 2014, 20 (13-14) : 2019 - 2029
  • [44] Effects of serum on in vitro and in vivo properties of human bone marrow stromal cells.
    Kuznetsov, SA
    Mankani, MH
    Collins, MT
    Robey, PG
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S355 - S355
  • [45] Isolation and culture of human bone marrow stromal cells
    Kovacs, IEL
    Wilkins, BS
    Jones, DB
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 33 - 33
  • [46] Arachidonic acid and human bone marrow stromal cells
    Denizot, Y
    Dulery, C
    Trimoreau, F
    Desplat, V
    Praloran, V
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1402 (02): : 209 - 215
  • [47] Repair of large bone defects by autologous human bone marrow stromal cells
    Marcacci, Maurilio
    Kon, Elizaveta
    Quarto, Rodolfo
    Kutepov, Sergei M.
    Mukhachev, Vladimir
    Lavroukov, Alexander
    Cancedda, Ranieri
    Key Engineering Materials, 2001, 192-195 : 1053 - 1056
  • [48] Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering
    Ciapetti, G.
    Ambrosio, L.
    Marletta, G.
    Baldini, N.
    Giunti, A.
    BIOMATERIALS, 2006, 27 (36) : 6150 - 6160
  • [49] In vitro control of human bone marrow stromal cells for bone tissue engineering
    Anselme, K
    Broux, O
    Noel, B
    Bouxin, B
    Bascoulergue, G
    Dudermel, AF
    Bianchi, F
    Jeanfils, J
    Hardouin, P
    TISSUE ENGINEERING, 2002, 8 (06): : 941 - 953
  • [50] Effect of lithium on growth of bone marrow stromal cells
    黄炜琦
    蒋德昭
    汪保和
    王绮如
    Chinese Medical Journal, 1999, (06)